Olympus Innovation Ventures Fund II

Olympus Innovation Ventures seeks to fortify its MedTech portfolio through strategic investments in early-stage companies with differentiated technologies in endoscopy-enabled care, including AI, robotics, and digital solutions for GI, urology, and respiratory diseases. By nurturing partnerships with visionary founders, the fund accelerates breakthrough technologies that improve patient outcomes, strengthen Olympus' leadership in endoscopy, and drive long-term growth in faster-growing segments.

Olympus Innovation Ventures Fund II is a $150 million corporate venture capital fund launched by Olympus Corporation, focusing on MedTech startups in gastrointestinal (GI), urology, and respiratory areas, particularly those advancing endoscopy-enabled care with devices, diagnostics, and digital health solutions. The fund invests in passionate founders revolutionizing medical solutions that complement Olympus' market-leading endoscopic technologies, from seed through growth stages globally. It builds on the success of the first $50 million fund, tripling the commitment to accelerate innovation in patient outcomes.

On Target Labs, Universal Diagnostics